These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 17540778)

  • 21. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells.
    Borger JG; Zamoyska R; Gakamsky DM
    Immunol Lett; 2014; 157(1-2):16-22. PubMed ID: 24263053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8 controls T cell cross-reactivity.
    Wooldridge L; Laugel B; Ekeruche J; Clement M; van den Berg HA; Price DA; Sewell AK
    J Immunol; 2010 Oct; 185(8):4625-32. PubMed ID: 20844204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes.
    Uhlin M; Masucci MG; Levitsky V
    Scand J Immunol; 2003 Feb; 57(2):99-106. PubMed ID: 12588655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An active CD8alpha/pMHCI interaction is required for CD8 single positive thymocyte differentiation.
    Kang YJ; Wang X; Lin SJ; Hsu YM; Chang HC
    Eur J Immunol; 2010 Mar; 40(3):836-48. PubMed ID: 19950178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.
    Clement M; Ladell K; Ekeruche-Makinde J; Miles JJ; Edwards ES; Dolton G; Williams T; Schauenburg AJ; Cole DK; Lauder SN; Gallimore AM; Godkin AJ; Burrows SR; Price DA; Sewell AK; Wooldridge L
    J Immunol; 2011 Jul; 187(2):654-63. PubMed ID: 21677135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts.
    Doucey MA; Legler DF; Boucheron N; Cerottini JC; Bron C; Luescher IF
    Eur J Immunol; 2001 May; 31(5):1561-70. PubMed ID: 11465114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes.
    de Vries JE; Yssel H; Spits H
    Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normalized Synergy Predicts That CD8 Co-Receptor Contribution to T Cell Receptor (TCR) and pMHC Binding Decreases As TCR Affinity Increases in Human Viral-Specific T Cells.
    Williams CM; Schonnesen AA; Zhang SQ; Ma KY; He C; Yamamoto T; Eckhardt SG; Klebanoff CA; Jiang N
    Front Immunol; 2017; 8():894. PubMed ID: 28804489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TCR internalization induced by peptide/MHC ligands requires the transmembrane domains of alphabeta chains of TCR, but not the expression of CD8 and Thy-1 molecules.
    Lee MH; Min D; Sonn CH; Lee KN; Kim KE; Paik SG; Kim YS
    Mol Cells; 1999 Dec; 9(6):617-24. PubMed ID: 10672928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crystal structure of CD8 in complex with YTS156.7.7 Fab and interaction with other CD8 antibodies define the binding mode of CD8 alphabeta to MHC class I.
    Shore DA; Issafras H; Landais E; Teyton L; Wilson IA
    J Mol Biol; 2008 Dec; 384(5):1190-202. PubMed ID: 18929574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.
    Luescher IF; Vivier E; Layer A; Mahiou J; Godeau F; Malissen B; Romero P
    Nature; 1995 Jan; 373(6512):353-6. PubMed ID: 7830771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
    Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
    J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery.
    Artyomov MN; Lis M; Devadas S; Davis MM; Chakraborty AK
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16916-21. PubMed ID: 20837541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor.
    Gao GF; Jakobsen BK
    Immunol Today; 2000 Dec; 21(12):630-6. PubMed ID: 11114424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.
    Irving M; Zoete V; Hebeisen M; Schmid D; Baumgartner P; Guillaume P; Romero P; Speiser D; Luescher I; Rufer N; Michielin O
    J Biol Chem; 2012 Jun; 287(27):23068-78. PubMed ID: 22549784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic and syngeneic class I MHC complexes drive the association of CD8 and TCR on 2C T cells.
    Lee PU; Kranz DM
    Mol Immunol; 2003 Jan; 39(12):687-95. PubMed ID: 12531280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
    Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
    Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation.
    Holler PD; Kranz DM
    Immunity; 2003 Feb; 18(2):255-64. PubMed ID: 12594952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.